PEN
Penumbra Inc
Halal Rating :
Last Price
$263.11
Last updated:
Market Cap
-
7D Change
6.55%
1 Year Change
4.1%
Company Overview
Industries
Exchange
Next Earnings Date
Penumbra Inc is a global healthcare company focused on innovative therapies. They design, develop, manufacture and market novel products for addressing challenging medical conditions primarily in vascular and neuro markets. The company specializes in interventional therapies, including stroke treatment devices, embolization devices for treating arteriovenous malformations, and thrombectomy systems for removing blood clots.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $301.04m | $265.68m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $299.4m | $380.36m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $278.65m | $266.55m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Penumbra Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.